BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17667248)

  • 1. Caveats for triple-H therapy in the management of vasospasm after aneurysmal subarachnoid hemorrhage.
    Hunt MA; Bhardwaj A
    Crit Care Med; 2007 Aug; 35(8):1985-6. PubMed ID: 17667248
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.
    Muench E; Horn P; Bauhuf C; Roth H; Philipps M; Hermann P; Quintel M; Schmiedek P; Vajkoczy P
    Crit Care Med; 2007 Aug; 35(8):1844-51; quiz 1852. PubMed ID: 17581487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which H is the most important in triple-H therapy for cerebral vasospasm?
    Treggiari MM; Deem S
    Curr Opin Crit Care; 2009 Apr; 15(2):83-6. PubMed ID: 19276798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative hypertensive-hypervolaemic-haemodilution (Triple H) therapy in the treatment of vasospasm following aneurysmal subarachnoid haemorrhage.
    Gupta D; Sharma BS; Gupta SK; Bapuraj R; Khosla VK
    Neurol India; 2000 Jun; 48(2):126-31. PubMed ID: 10878775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic augmentation in the treatment of vasospasm in aneurysmal subarachnoid hemorrhage.
    Gura M; Elmaci I; Cerci A; Sagiroglu E; Coskun KK
    Turk Neurosurg; 2012; 22(4):435-40. PubMed ID: 22843460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage.
    Sen J; Belli A; Albon H; Morgan L; Petzold A; Kitchen N
    Lancet Neurol; 2003 Oct; 2(10):614-21. PubMed ID: 14505583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple H therapy after aneurysmal subarachnoid hemorrhage. A review.
    Romner B; Reinstrup P
    Acta Neurochir Suppl; 2001; 77():237-41. PubMed ID: 11563296
    [No Abstract]   [Full Text] [Related]  

  • 8. "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
    Lee KH; Lukovits T; Friedman JA
    Neurocrit Care; 2006; 4(1):68-76. PubMed ID: 16498198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior reversible leukoencephalopathy due to "triple H" therapy.
    Jang HW; Lee HJ
    J Clin Neurosci; 2010 Aug; 17(8):1059-61. PubMed ID: 20488715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of hemorrhage from unsecured, unruptured aneurysms during and after hypertensive hypervolemic therapy.
    Hoh BL; Carter BS; Ogilvy CS
    Neurosurgery; 2002 Jun; 50(6):1207-11; discussion 1211-2. PubMed ID: 12015837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The present role of "triple-H" therapy in the management of cerebral vasospasm.
    Findlay JM
    World Neurosurg; 2010; 74(2-3):244-6. PubMed ID: 21492545
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of transcranial Doppler in optimizing treatment of cerebral vasospasm in subarachnoid hemorrhage.
    Darwish RS; Ahn E; Amiridze NS
    J Intensive Care Med; 2008; 23(4):263-7. PubMed ID: 18480082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic treatments of the vasospasm].
    Tavernier B; Decamps F; Vega E; Poidevin P; Verdin M; Riegel B
    Ann Fr Anesth Reanim; 2007 Nov; 26(11):980-4. PubMed ID: 17933488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of triple-h prophylaxis on global end-diastolic volume and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage.
    Tagami T; Kuwamoto K; Watanabe A; Unemoto K; Yokobori S; Matsumoto G; Igarashi Y; Yokota H;
    Neurocrit Care; 2014 Dec; 21(3):462-9. PubMed ID: 24865266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in vasospasm treatment and prevention.
    Komotar RJ; Zacharia BE; Valhora R; Mocco J; Connolly ES
    J Neurol Sci; 2007 Oct; 261(1-2):134-42. PubMed ID: 17570400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case report: Aneurysmatic subarachnoid hemorrhage -- complicated course due to coincidental manifestation of an inverted Tako-Tsubo-cardiomyopathy].
    Zech N; Kieninger M; Seemann M; Künzig H; Bele S; Dietl A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Jul; 49(7-8):428-34. PubMed ID: 25137200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral vasospasm in patients suffering from aneurysmal subarachnoid hemorrhage: an unresolved diagnostic and therapeutic challenge.
    Missler U
    Crit Care Med; 2009 Mar; 37(3):1150-1. PubMed ID: 19237943
    [No Abstract]   [Full Text] [Related]  

  • 18. Bedside monitoring of cerebral blood flow in patients with subarachnoid hemorrhage.
    Hegner T; Krayenbühl N; Hefti M; Yonekawa Y; Keller E
    Acta Neurochir Suppl; 2001; 77():131-4. PubMed ID: 11563271
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of balloon angioplasty on the evolution of vasospasm-related infarction after aneurysmal subarachnoid hemorrhage.
    Jestaedt L; Pham M; Bartsch AJ; Kunze E; Roosen K; Solymosi L; Bendszus M
    Neurosurgery; 2008 Mar; 62(3):610-7; discussion 610-7. PubMed ID: 18301345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic hypothermia in patients with aneurysmal subarachnoid hemorrhage, refractory intracranial hypertension, or cerebral vasospasm.
    Seule MA; Muroi C; Mink S; Yonekawa Y; Keller E
    Neurosurgery; 2009 Jan; 64(1):86-92; discussion 92-3. PubMed ID: 19050656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.